Skip to main content
TLLTF logo

TLLTF · TILT Holdings Inc.

Track TLLTF — free
Market Cap
$43,510
Shares
347.46M

No Price Data

No daily price data is available for this stock yet. Data syncs automatically from Yahoo Finance.

Up next

FQ3-26 quarter ends
~Sep 30, 2026 Est
filed Aug 14, 2025

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Limited Momentum Limited Sentiment Bullish Fundamentals Weak Quant / Vol Limited
Market backdrop VIX 14.9 · calm Equity put/call 0.70
Technical
price trend
Limited
Not enough data for a confident read.
Momentum
relative strength
Limited
Not enough data for a confident read.
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.14% of float · ▼ -2.0% MoM · 145.1 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Fundamentals
Weak
Revenue growth −30%
Y/Y
Gross margin 17%
expanding
EPS growth −63%
Y/Y
Free cash flow $-1.1M
Balance sheet $3.2M
net cash
Quant / Vol
risk profile
Limited
Not enough data for a confident read.

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Versus peers

Drug Manufacturers - Specialty & Generic — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
TLLTF
TILT Holdings Inc.
this stock
$43,510 -30.3% 0.1%
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
$66.37B 0.0%
TAK
Takeda Pharmaceutical Co Ltd
$57.58B +15.3% 0.1%
GALDY
Galderma Group AG/ADR
$49.38B -0.1% 0.0%
HLN
Haleon plc
$44.46B -0.8% 0.3%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Short & Settlement
Short Interest Falling
Shares short
487.8K
Days to cover
145.1d
Change
-10.0K sh
View
Short Volume
Short vol %
97%
As of
Apr 9, 2026
Short Total
View
Financials
Financials
Revenue (FY)
$115.6M
Net income (FY)
$-99.7M
EPS diluted
$-0.26
View
Filings
SEC Filings
Latest
8-K
Filed
Nov 20, 2025
This year
0
View
Exempt Offerings
Offering
$5.6M
Filed
Dec 22, 2023
View
Earnings & Events
Earnings Calls
Last call
Aug 14, 2025
View
Key facts CIK 1761510 Visit website